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CONSTRUCTING WHITENESS IN HEALTH DISPARITIES RESEARCH 
My project is an effort to avert the critical gaze from the racial object to the racial subject; from 
the described and imagined, to the describers and imaginers; from the serving to the served. 
--- Morrison, 1990:90 
 
INTRODUCTION 
Over the past two decades, the body of research documenting and examining racial differences in 
health has grown exponentially, from fewer than 20 publications between 1980 and 1989, to more than 
130 between 1990 and 1999, and over 700 in the first four years of the new millennium.i This literature 
has documented racial disparities in a substantial range of health outcomes, often comparing the health of 
one or more racialized groups to the health of “Whites.”  In other words, the search for explanations 
regarding the cause of racial disparities in health—and indeed, often the definition of racial disparities 
itself—is largely framed in terms of explicit or implicit comparisons of racialized groups to the referent 
group of White.   
Often unspoken and unexamined in these comparisons is the category of Whiteness itself: what it 
contains or represents and just what a comparison to Whites tells us.  Scholars examining the question of 
“Whiteness” have noted that, in contrast to other racial groups, Whiteness has often been defined by what 
it is not (Frankenberg, 1993; Fine, 1997)—not marked, not deficit, not raced.   
As Toni Morrison suggests in the quotation that serves as the epigraph for this chapter, there is a 
long tradition within the United States of constructing Whiteness (the racial subject) against racialized 
others (the racial object) and in the process displacing the focus of critical analysis.  Here we turn our lens 
to the often invisible—or at least underinterrogated—concept of Whiteness within the context of the 
literature on racial disparities in health.  Specifically, we examine how Whiteness is constructed in the 
active literature documenting and interpreting racial disparities in health and the implications of these 
constructions for efforts to eradicate inequalities in health.  We draw on the concepts of racial formation 
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and racial “projects” that emphasize the fluidity, mutability, and historically constructed nature of race, as 
well as the social and political processes through which racial categories are created and transformed 
(Nagel, 1996; Nobles, 2000; Omi and Winant, 2002; Stevens, 2003; Winant, 1997).  In particular, we 
apply Winant’s (1997) concept of “racial projects” to examine the construction of Whiteness in ongoing 
dialogues about race and racial disparities in health.  We consider the ways that varying constructions of 
Whiteness enter into, influence, and are influenced by discussions of racial disparities in health, and the 
role of those constructions in the reproduction or disruption of racial categories and the inequitable 
distribution of resources along racial lines. 
 
RACE AND RACIAL CLASSIFICATION IN HEALTH 
 
The problem of Whiteness and what it means or represents reflects larger dilemmas related to 
historical as well as contemporary constructions of race.  Questions regarding race as a scientific category 
transcend disciplinary boundaries (e.g., Freeman, 1998; American Anthropological Association, 1998; 
Duster, 2003b), reflecting the pervasive influence of racialized thinking in scientific endeavors. Although 
widely used as analytic categories, racial classification systems have been soundly critiqued as 
unscientific, poorly defined, and contingent upon both historical and geographic context.  Despite 
persistent associations between racial categories and health outcomes, scholars both within and outside of 
public health continue to raise critical questions about the use of racial classifications as analytic 
categories (Bhopal, 1998; Duster, 2003a; Epstein, Moreno, and Bacchetti, 1997; Farley, Richards, and 
Bell, 1995; Hahn, 1999; Hahn and Stroup, 1994; Hahn, Mulinare, and Teutsch, 1992; Hahn, Mendlein, 
and Helgerson, 1993; Jackson, 1989; Kaufman, 1999; Mullings, 2004; Nobles, 2000; Witzig, 1996; 
Williams, 1997), including questions about their relation to historical processes that created contemporary 
inequalities, contemporary definitions, meanings, and interpretations, and their limits in identifying 
etiological pathways through which differential health outcomes are produced.     
Critics point to the lack of a biologic, genetic, or other “scientific” basis for racial classification 
systems and ensuing difficulties creating clear and consistent definitions (Hahn, 1999; Kaufman, 1999; 
 
 4 
Hahn, Mendlein, and Helgerson, 1993).  Two illustrative examples involve classifications employed in 
census data and birth certificates, both commonly used in health research in the United States.  In 1790, 
the U.S. Census included three categories: Free Persons (White, and all other free persons except Indians 
not taxed); slaves (counted as 3/5 of a person); and Indians living on reservations (not taxed).  By 1850, 
categories had shifted to more explicitly racial language, denoting simply “white” and “free person of 
color.” By 1890, an expanded range of racial categories included “white”; “black” (persons with ¾ or 
more Black ancestry); “mulatto” (1/2 Black ancestry); “quadroon” (1/4 Black ancestry); and “octoroon” 
(1/8 Black ancestry).  By 1910, these categories had contracted to aggregate the previous distinctions in 
percent ancestry into just “white,” “black,” and “mulatto” categories.  In 1930 and 1940, census takers 
were instructed to categorize individuals with White and American Indian ancestry as “Indian,” and those 
of African and American Indian ancestry as “African” “unless Indian blood definitely predominates” 
(Forbes, 1993:12).  In other words, any American Indian ancestry overrode White ancestry to identify 
individuals as Indian (not White), while African ancestry overrode American Indian ancestry, except in 
cases where African ancestry was small. And, of course, the U.S. racial paradigm of hypodescent means 
that a small amount of African ancestry overrides a much larger amount of European ancestry.  The 2000 
Census reflected renewed expansion of racial options, including five racial categories and two ethnic 
categories [Hispanic or Latino; and not Hispanic or Latino]. Respondents were allowed to indicate both 
race and ethnicity (OMB, 1978), further expanding the range of ethnic options available.  The historically 
contingent nature of these racial categories highlights their socially and politically constructed nature and 
belies any coherent biological basis or interpretation of contemporary racial groups (Nobles, 2000). 
Similarly, racial classification systems used on birth records in the United States reflect changing 
gender as well as racial ideologies and practicalities.  Prior to 1989, the race of infants indicated on birth 
certificates was derived using a complex algorithm.  Specifically, infants’ race was coded as paternal race 
regardless of maternal race, with two exceptions.  In instances where the father’s race was White and the 
mother’s race was any other, maternal (rather than paternal) race was used to define the infant’s race.  In 
contrast, if either parent was Hawaiian, the infant’s race was coded as Hawaiian on the birth certificate.  
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In 1989, this system of racial classification was modified, in part due to increasing numbers of children 
born for whom the father was not present and therefore father’s race was unknown. Both the previous and 
the current system systematically simplify hereditary complexities, although using different racial and 
gender heuristics to do so.  The examples of the census and birth certificate racial categories highlight the 
historical, social, and political nature of racial classification systems and make clear their limitations as 
indicators of biological or genetic makeup (see Hahn, Mendlein, and Helgerson, 1993; Cooper and David, 
1986; Cooper and Freeman, 1999; Kaufman, 1999; Watson and others, 1993 for more detailed 
discussions of the limitations of racial classification systems as indicators of biological or genetic 
composition).  
These illustrations of the socially, historically, and politically contingent nature of race, combined 
with the persistent interpretation of racial categories that emerged out of the specific historical and 
political context of the United States as scientifically meaningful, have contributed to lively debate about 
how persistent racial differences in health outcomes are best understood and addressed.  Even as race is 
increasingly recognized as a social construct and racial categories as problematic from an analytic 
perspective (Bhopal and Donaldson, 1998; Fullilove, 1998; Williams, 1997; Witzig, 1996), scholars differ 
as to how best to address this problem.  Some have suggested that “race” should be abandoned entirely in 
public health research (Fullilove, 1998) and replaced by explicit attention to the political and social 
processes that it represents (e.g., socioeconomic differences, racial discrimination).  Others, who would 
concur that we must explicitly attend to the political and social processes that create racial disparities in 
health, argue that we must continue to use racial and ethnic categories to monitor progress toward 
elimination of racial disparities (Baker, 1998; Duster, 2003a; LaVeist, 1994; Mullings, 2004).  In other 
words, racial categories reflect racialized social systems in the United States, and those systems impact 
the health of groups defined by race differently.  Attaining equitable health outcomes can only be 
assessed if we continue to monitor the health of racially defined groups, recognizing that these differences 
are produced through social and political processes. 
Even as these discussions about how best to recognize the socially constructed nature of race 
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have emerged, interpretations of race as reflecting immutable characteristic of individuals continue, with 
racial differences in health viewed as emerging from biologic or genetic differences (Hernstein and 
Murray, 1994; Last, 1995; Rushton, 1994; Snyderman and Rothman, 1988).  Understanding this struggle 
over the very meaning of “race” is central to an analysis of the interplay of race, gender, and class in 
health, as well as to an understanding of Whiteness both within health and in United States social and 
political systems more broadly. 
These debates about the validity and certainly the reliability of the construct of race as an analytic 
category have unfolded in the context of a virtual explosion of research drawing attention to racial 
differences in health and mortality over the past quarter century. Within this literature, the most common 
referent group is “White” (or, more rarely, Caucasian, European, or Western) (Bhopal, 1998).  Despite 
critical examination of the homogenizing influence of racial or ethnic categories that collapse diverse 
national, linguistic, and other identity groups into a single category (e.g., Gimenez, 1989; Williams, 
Lavizzo-Mourey, and Warren, 1994) and a trend toward increasing complexity of comparisons within 
various racialized groups (e.g., disaggregating analyses of Blacks into African Americans and Afro-
Caribbeans; disaggregating “Latinos” into Cuban, Puerto Rican, and Mexican American), there has been 
relatively little critique of the aggregation of multiple groups into the “White” racial category (Bhopal, 
1998). Furthermore, there has been relatively little explicit examination in the public health literature of 
how some groups come to be defined as White and the subsequent implications for health. How is it that 
the category of White or Whiteness is both pervasive as a comparison or referent group in the literature on 
racial disparities in health and at the same time its composition and the meaning or interpretation of 
comparisons to “Whites” remains largely uninterrogated?  And perhaps more importantly, what are the 
implications of this invisibility for understanding and addressing the inequalities in health with which this 
literature is concerned? 
To begin to examine this question, we borrow the concept of “racial projects.” This concept 
emerged in an attempt to capture the active and dynamic efforts of social groups to organize the 
distribution of resources along racial lines (Omi and Winant, 2002).  Conceptualizing Whiteness, like 
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other racial categories, as socially constructed allows Whiteness to be examined as dynamic, as actively 
created and maintained, rather than as static, given, or immutable. Thought of in this way, Whiteness is 
not genetically derived or granted but is accomplished through the active efforts of human beings who 
construct and maintain social boundaries—for example, defining who is White and who is not (see Buck, 
2001; Daniels, 1997; Ignatiev, 1995).  Creating and maintaining Whiteness as a bounded category that is 
largely not visible or marked, and yet manages to retain privilege, is neither a modest nor a simple 
venture. A defining feature of Whiteness, then, is the absence or unmarked invisibility of “White” as a 
racial category. As many scholars have noted, this invisible and absent quality of Whiteness is itself a 
mechanism of privilege (Allen, 1993; Dyer, 1998; Feagin and Vera, 1994; Fine and others, 1997; 
Frankenberg, 1993; Ignatiev, 1995; Kincheloe and others, 1998; McIntosh, 1988; Roediger, 1991; 1998), 
deflecting attention from Whiteness while simultaneously playing a role in the racialization of those 
groups that are defined as not “White.”     
Winant suggests that “the problem of the meaning of whiteness appears as a direct consequence 
of the movement challenge posed in the 1960s to white supremacy” (Winant, 1997:48-49).  As civil rights 
movements disrupted previously homogeneous notions of Whiteness, Whites and Whiteness were no 
longer exempt from the complex racialization processes that are the hallmark of U.S. history (Winant, 
1997:48).  Rather, Whiteness has become a more contested and visibly negotiated racial category. The 
disruption of the homogeneity of Whiteness brought about by the Civil Rights Movement opened up both 
the possibility of an interrogation of White privilege, as well as challenges to civil rights legislation such 
as affirmative action through newly galvanized Whites who envisioned themselves as under attack.   A 
series of recent scholarly works has examined in detail the intersections of race and gender, and in some 
cases class and religion, in negotiations that define who is White and who is not, as well as the meaning 
of inclusion in various racial categories (e.g., Buck, 2001; Daniels, 1997; Chehade, 2001; Majaj, 2000; 
Ferber, 2004).  The concept of “Whiteness projects” encourages explicit analyses of active efforts to 
negotiate conceptualizations of Whiteness that, in turn, may serve to reproduce or to disrupt racial 
inequalities.   
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Winant has sketched several useful typologies for understanding contemporary “white racial 
projects”: far right, new right, neoconservative, neoliberal, and new abolitionist (1997).  He describes the 
Whiteness project of the far right as putting forward biological notions of race as part of a racialized 
ideology that views racial differences (racial hierarchies) as immutable and inherent, grounded in genetic 
or biological difference.  Effectively, this conservative racial project seeks to maintain White privilege 
through the argument that Whites are genetically or biologically distinct from and superior to other racial 
groups. 
Winant describes new right racial projects as differing from those of the far right in their 
acceptance of participation by members of non-White racial groups, provided that such participation “is 
pursued on a ‘color-blind’ basis and adheres to the rest of the authoritarian, nationalist program” (Winant, 
1997:44; see also Mullings, 2005).   Despite the appearance of inclusiveness of non-White racial groups, 
new right racial projects emphasize the maintenance of White racial privilege through cultural 
representations of race that play on racial fears and exacerbate divisions among racial groups—for 
example, through the 1988 Willie Horton campaign ads employed by George Bush (Winant, 1994:44). A 
more recent example comes from Wilton’s (2002) case study of community opposition to the placement 
of “special needs” housing in a San Pedro, California, neighborhood.  Wilton demonstrates the ways 
opponents to the housing project galvanized a NIMBY campaign that deployed a romanticized, European, 
and “Whitened” construction of community which marked “special needs” as outsiders, unwelcome and 
unwanted in the community.  Wilton’s case study provides an example of the ways in which the new right 
racial project of Whiteness emphasizes the maintenance of White racial privilege through cultural 
representations of race that play on racial fears and exacerbate divisions among racial groups. 
Neoconservative Whiteness is similarly rooted in the politics of the right but seeks to preserve 
White advantage through denial of racial difference (1997).  Such efforts simultaneously valorize 
universalism and individualism, and in so doing they seek to obscure or deny differences that may emerge 
from social inequalities. For example, in The End of Racism (1995), D’Souza writes that  “racism can be 
overcome” by “revising our most basic assumptions about race,” including the notion that “Affirmative 
 
 9 
Action is a policy that assures equal opportunity for disadvantaged African Americans and other 
minorities” (1995:2-3).   D’Souza and other neoconservatives’ opposition to affirmative action policies 
simultaneously appeals to universalism (job or academic performance standards) and individualism 
(achievement in meeting those standards).  Thus, for neoconservatives, “the end of racism” comes with 
renewed focus on universal standards and individual achievement without regard to race.   Yet the focus 
on universal, race-blind standards within a context in which race still matters (that is, in which Whites are 
more likely to have access to the kinds of material and social resources that enable them to achieve those 
standards) is a strategy that reinforces and privileges Whiteness.  Advocates are actively working to make 
this “colorblind” racial project the underpinning of contemporary legal theory and social practices 
(Mullings, 2005).  
In contrast to these projects, neoliberal Whiteness “seeks to limit white advantage through denial 
of racial difference” (Winant, 1997:45).  Winant describes neoliberal Whiteness projects as encompassing 
social democratic political perspectives that focus on social structure, as opposed to the cultural 
representations of race that are employed in the various right-wing racial projects.  Within this Whiteness 
project, inherent racial differences are negated, and any systematic racial inequality is attributed to 
structural, often economically rooted, phenomena.   Neoliberal Whiteness maintains that if structural 
disadvantages that disproportionately affect Black, Hispanic, and Native American groups were 
equalized, then racial differences would disappear.  
The final category in Winant’s typology is new abolitionist racial projects.  New abolitionist 
projects emphasize the historical development of Whiteness and White privilege as central to the 
emergence of U.S. capitalism.  These studies focus attention on the relations between historical 
formations of race and class in the U.S. and promote the deconstruction or repudiation of White racial 
privilege.   Here we employ Winant’s notions of various racial projects as a way of continuing the 
disruption of homogenous Whiteness as it is constructed in health disparities research.   To do this, we 
examine the constructions of Whiteness that emerge within the context of two literatures in public health: 
broadly, the literature on racial disparities in health that focuses on social structural explanations for those 
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differences, and discussions of genetic explanations for racial health disparities that have emerged in the 
wake of the Human Genome Project.  
 
CONSTRUCTING WHITENESS IN THE CONTEXT OF RACIAL DISPARITIES IN HEALTH 
 
The literature on racial disparities in health by definition involves comparisons across groups 
defined by some racial classification system.  Perhaps the most common of these comparisons take the 
form of the following general proposition: [Black/Hispanic/Native American] [children or adults] have 
higher rates of [the condition, disease, or “disability” under investigation] than Whites, primarily 
because of [explanatory variable]. 
This proposition constructs Whiteness in two ways.  First, it establishes a comparison between 
Whites as a referent group and some “other” group whose health is evaluated in comparison to that of 
Whites.  In an ideal world, such comparisons may demonstrate arenas in which health outcomes do not 
differ by race, challenging ideas of racial group difference.  If, however, funders are less likely to support 
research in areas in which substantial racial differences are not apparent, or if publishers are less likely to 
publish articles that find no statistically significant differences (see Phillips, 2000; Scargle, 2000; Stern, 
1997 for discussions of publication bias), the literature will reinforce racial health differences while 
minimizing similarities (Gould, 1996; Lewontin, Rose, and Kamin, 1984, Stevens, 2003, Tucker, 1996).   
Equally important, however, are the theoretical or conceptual frameworks that underlie questions 
about racial disparities.  Whether such theoretical frameworks are implicit or explicit, they guide the way 
that research questions are framed, as well as the interpretation of results.  We have already noted the 
absence of a “scientific” foundation for racial categories or even a clear and shared definition of what race 
is across and, in some cases, within disciplinary boundaries.  Precisely because of the socially constructed 
and situated nature of racial constructs, comparisons of racial groups “leave room for multiple 
interpretations, including biologic or cultural notions of race as an essential or unchanging constituent of a 
person” (Muntaner 1999:122).  In other words, the use of racial categories and comparisons with no 
consistent foundation for theorizing, understanding, or interpreting observed racial differences (or their 
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absence) in health outcomes provides space for a wide range of potential explanations.  Each of these 
“explanations” implicitly or explicitly constructs both race and Whiteness.  
For example, within the literature on racial disparities in cardiovascular disease, comparisons of 
Black or Latino/a to White Americans show disparities not only in cardiovascular mortality rates (Cooper 
and others, 2000; Wong and others, 2002) but also in multiple risk factors, including high blood pressure 
(Cooper and Rotimi, 1997; National Heart Lung and Blood Institute, 2004; Crespo, Loria, and Burt 
1996), obesity (James, 1999; Kumanyika, 2001), physical activity (Brownson and others, 2001; Crespo 
and others, 1996), and intake of micronutrients and macronutrients associated with cardiovascular risk (Li 
and others, 2000).  In the absence of an explicitly social theory of race, analyses explaining racial 
disparities in cardiovascular disease in terms of biological, “lifestyle,” or “cultural” factors can reify racial 
differences and obscure connections to socially structured inequalities. In other words, explaining racial 
differences in health in terms of individual biology, genes, or behavior can locate health problems in the 
bodies of those most negatively affected by social inequalities.  Such explanations fail to make explicit 
connections to histories of racism and the struggles against oppression by subordinated groups (Bonilla-
Silva, 2003; Mullings, 2005).  In the process, they also take out of the equation—and thus make 
invisible—the processes through which Whites maintain positions of relative advantage or privilege 
within racial hierarchies.  In this sense, such explanations are consistent with the “colorblind” strategies 
of neoconservative and neoliberal Whiteness projects described above, in that they explain racial 
disparities in health in nonracial terms.  The example of cardiovascular disease is one to which we will 
return in a moment.  First, we want to place this discussion within an historical context.  
The failure to make explicit connections between biologic and behavioral factors and race as a 
socially constructed system of inequality can also reinforce racial inequalities by playing on racial fears to 
exacerbate divisions between groups.  An historic example of this is offered by Shah (2001), who 
describes the explicit construction of Chinese immigrants living in cramped, substandard housing in San 
Francisco.  The communicable diseases that were, not surprisingly, common under these conditions were 
constructed as a “pestilence” that posed a “danger to the white public” (Shah, 2001:251).   Here the 
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disproportionate occurrence of communicable diseases among Chinese immigrants led to constructions 
that associated disease with the Chinese immigrants themselves rather than with their relative 
disadvantage within a racial system, which led to their disproportionate residence in substandard housing.  
Even more extreme is the construction of “Negro diseases” such as drapetomania (running away from 
enslavement), which defined resistance to slavery as a mental illness (Williams and Harris-Reid, 1999).  
Samuel A. Cartwright, M.D., writing on this topic in the 1850s, said, “With the advantage of proper 
medical advice, strictly followed, this troublesome practice that many Negroes have of running away can 
be almost entirely prevented.” The recommended treatment was whipping, as well as keeping slaves in a 
submissive state and treating them like children, with “care, kindness, attention to humanity to prevent 
and cure them from running away” (Cartwright, 1981:71; Jackson, 2002; Wren, 1985). Defining 
individual responses to enslavement as a mental illness requiring treatment provided a justification for 
continued enslavement, with treatment of the medical condition the responsibility of the slave owner 
(Szasz, 1971).  Simultaneously, locating the “problem” within the bodies and minds of slaves shifted the 
lens away from the structured economic system of slavery and the White slaveholders whom it benefited. 
More recent examples can be found in the literature on HIV/AIDS, in which the identification of 
HIV/AIDS among Haitians and gay men contributed to stigmatization of affected communities and 
impeded effective response (Altman, 1986; Brandt, 1987; Cohen, 1996; Sontag, 1989).  In each of these 
examples, the identification of a particular group most negatively affected by a health or social condition, 
combined with cultural representations that play on racial fears and stereotypes, serves to define particular 
health concerns within those groups most harmed, contributes to their stigmatization, and obscures White 
privilege in a manner that is consistent with Winant’s typology of new right Whiteness projects.  
Examples such as these demonstrate the processes through which the causes of racial disparities 
in health can be located within those groups most visibly affected, rather than in the social relations that 
systematically advantage Whites in relation to other racial groups.  What remains invisible is Whiteness 
itself, as well as its role in the process of creating and sustaining racial disparities in health by 
contributing to unequal access to the resources necessary to maintain health.  The failure to explicitly 
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conceptualize race as a set of social relations leaves descriptions of racial differences in biological or 
behavioral factors associated with differential health outcomes open to interpretations as produced 
through biological, genetic, or culturally patterned lifestyle differences.  In other words, they “explain 
racial inequality as the outcome of nonracial dynamics” (Bonilla-Silva, 2003:2), a hallmark of “colorblind 
racism.” Such studies can be interpreted in ways that foster neoliberal, neoconservative, or new right 
Whiteness projects.   
In an effort to move toward a more explicit analysis that links racial disparities in health to social 
contextual factors, a literature on social disparities in health has emerged. This literature attempts to 
address the discrepant “life-chances” between poor or working-class and middle-class people and 
between Whites and Blacks, Hispanics, or other racialized groups.  This body of research attempts to 
explain racial and class differences in health outcomes through the identification of unequal exposures to 
social conditions that influence health—for example, access to employment opportunities, exposure to 
unfair treatment, or exposure to noxious environments. 
To return to our earlier example of racial differences in cardiovascular disease, research framed in 
terms of social determinants of health might attempt to explicitly link racial disparities in cardiovascular 
disease to differentials in access to the resources or environments necessary to maintain health.  Studies in 
this vein examine, for example, racial or socioeconomic variations in access to healthy and affordable 
fruits and vegetables and their implications for dietary practices (Cheadle and others, 1991; Morland and 
others, 2002; Nestle and Jacobson, 2000; Swinburn, Egger, and Raza, 1999; Travers, 1996; Zenk and 
others, 2005), access to educational and employment opportunities and their implications for 
socioeconomic status (Massey and Denton, 1993; Orfield, 1993; 2001; Wacquant and Wilson, 1989), the 
location of health care providers and pharmacies and their implications for access to health care 
(McLafferty, 1982; Whiteis, 1992), and neighborhood concentrations of poverty and wealth and 
implications for cardiovascular risks (Diez-Roux and others, 2001; Kaufman, Cooper, and McGee, 1997).  
This literature reflects a move toward a more explicit theoretical conceptualization of racial disparities in 
health as resulting from differential access to the resources necessary to maintain health (e.g., education, 
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income, access to nutritious foods), which, in turn, influence health-related behaviors and biological 
processes associated with cardiovascular disease.  
How is Whiteness constructed in this literature?  Explanations of racial disparities in health that 
focus attention on differential access to resources to promote health (e.g., grocery stores) and differential 
exposure to environments that are not conducive to health (e.g., restricted employment opportunities) shift 
the explanatory lens from the biology and the behaviors of racialized groups to the contexts within which 
people reside.  This explanatory shift, depending on the theoretical framework and the explanation for 
why there is differential distribution of resources conducive to health, may help disrupt racial categories. 
Specifically, these analyses test the extent to which racial differences in health emerge from 
differences in social environments rather than from differences in inherent characteristics of racial groups.  
They seek to document the contributions of differential access to health-promoting resources and 
differential exposure to health risks.  They essentially suggest that there are not inherent differences 
between racial groups but that differences in health emerge through differences in the social determinants 
of health.  Extending the argument that race would not matter if exposures to “x” were more equitably 
distributed contributes to understanding how social conditions contribute to or create racial differences in 
health.  However, without an explicit analysis of how risks come to be distributed differentially, such 
analyses stop short of making the theoretical or empirical link to the processes that create these unequal 
distributions of resources and risks.  In other words, they fail to specifically theorize the ways that racial 
categories and racialized processes contribute to the accrual of advantage by Whites and the extent to 
which those benefits accrue at the expense of non-White people’s health.  This leaves Whiteness, and 
specifically the way Whiteness is protective of health, unmarked, invisible, and unnoticed.  Given that the 
research is ostensibly addressing the issue of “race,” and indeed disparities in health, the invisibility of 
Whiteness in this context becomes all the more difficult to name.   
Much of this literature, however, is more explicit in theorizing the processes through which 
Whiteness accrues privilege while disadvantage accumulates among racially labeled groups.  For 
example, an active body of research explicitly examines the ways that race-based residential segregation 
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and urban renewal efforts have served to concentrate poverty and disadvantage in segregated Black or 
Latino/a urban communities while concentrating wealth and advantage in segregated White communities, 
with subsequent implications for health (Acevedo-Garcia and others, 2003; Fullilove, 2004; Schulz and 
others, 2002; Williams and Collins, 2001). This work links processes of racialization and discrimination 
to the distribution of resources available to maintain health, probing the ways that Whites accrue 
advantage and Blacks, Latinos/as, and other racialized groups accrue systematic disadvantage in terms of 
exposures to risks and access to protective factors.  Similarly, analyses that probe the intersections of race 
and gender and class, including the racialized and gendered nature of the labor market, help to explicate 
the reciprocal nature of advantage and disadvantage and their role in producing racial disparities in health 
(Mullings and Wali, 2000; Mullings, this volume).    
Finally, analyses that turn the lens on the cultural production of difference and differential access 
to the means of constructing cultural interpretations (see Geronimus and Thompson, 2005; Weber, this 
volume) further interrogate the production of inequalities, including the role of Whiteness in sustaining 
systems of racial inequality.  Explicit examinations of Whiteness projects can make more visible the 
processes through which racial hierarchies are reproduced.  Bringing such analyses to research on racial 
disparities in health moves us toward what Winant has termed “new abolitionist” Whiteness projects, 
those that explicitly focus on deconstructing or decentering White racial privilege by analyzing the 
construction of Whiteness. Placing Whiteness under such a critical lens in future studies of racial 
disparities in health can contribute to an examination of the complex forms that Whiteness projects take, 
ranging from those that reproduce racial hierarchies to those that may disrupt and potentially transform 
those hierarchies.  Scholars have raised important concerns and caveats about contemporary 
investigations of Whiteness (Arnesen, 2001; Fine, 1997; Stein, 2001; Winant, 1997) while encouraging 
continued critical attention to the contribution of Whiteness in social, political, and cultural processes that 
perpetuate racial inequalities. 
In the following section, we examine the emergence of various Whiteness projects within the 
context of the Human Genome Project over the past decade or so.   Building on our analysis of the 
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absence of an explicit theory of race as a set of social relations, we examine how that absence enables the 
production of a variety of racial projects that construct Whiteness while enabling it to remain relatively 
invisible.  This invisibility facilitates Whiteness projects that simultaneously perpetuate inequalities (and 
thus disparities in health) while undermining the potential for more transformational Whiteness projects 
that could contribute to the disruption of racial hierarchies and the health disparities that they produce.    
 
CONSTRUCTING WHITENESS THROUGH GENETIC EXPLANATIONS FOR RACIAL 
DISPARITIES 
 
Writing in 1997, Winant asserted that the neoconservative racial project was “far more 
complicated now than ever before, largely due to the present unavailability of biologistic forms of racism 
as a convenient rationale for white supremacy” (Winant 1997:45).  However, in the first years of the 21st 
century, there has been a dramatic resurgence in the availability of biology as an explanation for 
persistent racial differences.  In fact, the interest among scholars, mainstream media, and the lay public in 
biological or genetic explanations for differences between racial groups has been so pronounced that 
Barbara Katz Rothman describes this “genetic frame” as a new “way of thinking” (2001:2).   While not 
the equivalent of the biologistic racism of the far right racial project, the biologically based individualism 
of neoconservative Whiteness constructs and reinforces notions of “race’” as fixed, rooted in physical 
bodies rather than in social constructs, while it also seeks to abrogate racial disparities in health.   The 
interplay of assumptions and constructions of race and the inevitably of Whiteness are visible as 
discussions of genomic research, particularly aspects of genomic research concerned with racial 
disparities, unfold.  
 
Background to Human Genome Research   
 
Genomic research, and in particular the Human Genome Project (HGP), has substantially altered 
biomedical and health research in racial disparities, precipitating a move toward analysis of genomic 
characteristics of individuals or groups (Duster, 2003a; 2003bHaraway, 1997; Katz Rothman, 1998; 2001; 
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Stevens, 2002; 2003).   Begun in 1990 and completed in 2003, the Human Genome Project was 
conducted by an International Human Genome Research Consortium.ii   Alongside this academic 
consortium, a number of privately owned biotechnology firms, such as Celera, began attempts to map the 
human genome, with an eye toward turning a profit from genetic knowledge, particularly in the field of 
health (Malakoff and Service, 2001).   The goal of both the privately funded efforts and the academic 
Human Genome Project was to “analyze the structure of human DNA and to determine the location of an 
estimated 100,000 human genes” (Guyer and Collins, 1993). The completion of the HGP has made it 
possible to identify and isolate human genes, particularly those associated with disease (van Ommen, 
2002). Completion of the Human Genome Project and mapping of the human genome single-nucleotide 
polymorphisms (SNPs) are widely regarded, both by genomic researchers and the lay public, as holding 
out great promise for the future of diagnostics, treatment, and prevention of disease (Chice, Cariou, and 
Mira, 2002; Wade, 2002b).   
Frequently considered the medical equivalent of landing on the moon, the HGP seemed to offer 
improved opportunities for early diagnosis and treatment when, in 1994, two leading scientists wrote that 
“The ability to predict the development of disease makes possible early intervention to limit the severity 
of a disease or to use gene therapy to cure inherited disorders” (Gottesman and Collins, 1994:591).   
While some have tempered their enthusiasm in the years since the start of the HGP, neither the unfulfilled 
goal of early diagnosis and intervention to limit the severity of disease nor the illusive promise of gene 
therapy to cure inherited disorders has deterred ardent proponents of the possibilities of genomic research 
for disease diagnosis, prevention, and treatment (Stevens, 2003).  
The Human Genome Project, and genomic research more broadly, are having a ripple effect on 
public health research agendas having to do with disparities.  Evidence of this genomic ripple effect can 
be seen in the growing body of literature that addresses the implications of genomic research for health 
promotion and disease prevention (Austin, Peyser, and Khoury, 2000; Khoury, Burke, and Thomson, 
2000; Beskow and others, 2001; Chadwick, 2004; Gerard, Hayes, and Rothstein, 2002; Wilkinson and 
Targonski, 2003).  This emerging literature calls for a variety of responses to genomic research by those 
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who work in public health, including “how to address barriers to widespread application” (Gerard, Hayes, 
and Rothstein, 2002) and “the integration of genomic competencies among public health professionals” 
(Beskow and others, 2001). At the same time, a more critical voice has emerged among scholars within 
public health, medicine, genetics research, and related disciplines calling for a more equivocal and 
nuanced response to the emergent emphasis on genetic solutions to public health concerns (Anderson and 
Nickerson, 2005; Bonham, Warshauer-Baker, and Collins, 2005), including a concern about 
overemphasizing genetic explanations for public health problems (Kaufman and Hall, 2003; Stevens, 
2003).  Funded in the United States by the National Institutes of Health (NIH), the HGP had an annual 
budget of approximately $350 million, easily making it the largest recipient of NIH funds.  Some have 
speculated that in the wake of NIH sponsorship of the HGP, it will be increasingly difficult to obtain NIH 
funds for public health research that does not address genomes, such as environmental and behavioral 
health research (Wilkinson and Targonski, 2003).  We contend that this shift toward the genomic has 
profound implications for an understanding of racial disparities in health and, in particular, the 
reproduction of Whiteness within public health research and practice that seeks to address racial 
disparities.   
 
Whiteness and the Human Genome  
 
 The director of the National Human Genome Research Institute (NHGRI) at the National Institutes 
of Health, Francis Collins, has stated that the HGP “helped to inform us about how remarkably similar all 
human beings are—99.9% at the DNA level. Those who wish to draw precise racial boundaries around 
certain groups will not be able to use science as a legitimate justification” (Collins and Mansoura, 
2001:221).  Other scientists working in the area of population genetics often (though not universally) echo 
this disavowal of the existence of race: "One important conclusion of human population genetics is that 
races do not exist" (Cavalli-Sforza, 1997:52-53).  As one researcher has noted, referring to Hernstein and 
Murray’s 1994 work, “This is not the sociobiology seen in The Bell Curve, in which genetically based 
intelligence differentials are asserted to characterize different races” (Dunklee, 2003:154).  Reframed 
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within Winant’s typology, this is not the essentialism of the far right Whiteness project.  Rather, the HGP 
resonates with neoconservative Whiteness projects as it universalizes, emphasizing similarities in human 
genetic material across races, while it simultaneously elevates the individual.  This is particularly evident 
in both the sampling for the HGP and the claims based on those samples.    
Rarely mentioned in the literature, and even less often scrutinized, are the samples and the 
sampling strategy used in the Human Genome Project and the associated private ventures on which this 
claim of “shared humanity” is based.  Scientists working on the HGP from both the academic consortium 
and the privately funded biotechnology firms originally proposed to include a “diverse” sample of DNA 
for mapping the human genome: that is, chromosomal samples taken from people of a variety of racial 
and ethnic backgrounds.  For example, the website for the academic consortium responsible for the 
Human Genome Project in the U.S. indicates that “candidates were recruited from a diverse population” 
(http://www.genome.gov/11006943).  The private effort to map the human genome, led by the biotech 
firm Celera, claimed to be using an even more deliberately “diverse” chromosomal sample.  Venter and 
others (2001) write, “Celera and the IRB believed that the initial version of a completed human genome 
should be a composite derived from multiple donors of diverse ethnic backgrounds” (Venter and others, 
2001:1306).  DNA samples were collected from 21 volunteer male and female donors who self-identified 
their racial/ethnic category (Venter and others, 2001:1306).  From those 21 donors, DNA was selected 
from five subjects (one African American, one Asian Chinese, one Hispanic Mexican, and two 
Caucasians, two of whom were male and three female (Venter and others, 2001:1307).  The decision 
about whose DNA to sequence was based on “a complex mix of factors, including the goal of achieving 
diversity, as well as technical issues such as the quality of the DNA libraries and availability of 
immortalized cell lines” (Venter and others, 2001:1307).  Thus, both the academic consortium and the 
private firm involved in mapping the human genome originally sought to include DNA from people of 
diverse racial/ethnic backgrounds as well as gender.  Upon completion of 90% of the mapping project, 
Collins of the NHGRI and Venter of Celera—former competitors in the race to map the human genome—
held a joint press conference with President Clinton to announce the completion of a “rough draft of the 
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human genome” (Wade, 2000), ostensibly on this diverse sample of DNA.   
However, both the academic HGP and the privately funded mapping project have been criticized 
for not selecting a sample that is diverse enough to serve as the map of the human genome (Jackson, 
1997).    In point of fact, the chromosomal reference samples for the academic HGP were taken from 
“sixty-seven northern American and northern European men” with a large portion oversampled from Utah 
(Stevens, 2002:110).   As for the private venture at Celera, after the project was completed, Celera’s CEO 
Craig Venter revealed the mapping that his firm had done had not been on the “diverse” chromosomal 
sample of donated DNA but rather on his (Venter’s) own DNA (Wade, 2002a).  Explaining the use of his 
own DNA, Venter cited both “privacy concerns” for volunteers who submitted DNA to the project and 
his curiosity about the uniqueness of his own DNA (Wade, 2002a).iii   The point of noting this 
discrepancy here between the claim of shared genetic universality and the limited sampling diversity (to 
vastly understate the case) of DNA actually used for mapping the human genome is to raise one of the 
central dilemmas for those interested in critically engaging the genomic literature and the construction of 
Whiteness.  On the one hand, charging that the DNA sample was not “diverse enough” across racial and 
ethnic groups presumes that there are significant genetic racial differences between groups that should be 
studied.   Indeed, Fatimah Jackson argues forcefully against the applicability of the heavily North 
American and northern European sample of the HGP to people who are descendants of African ancestors 
(1997).   She calls for separate genetic studies of Africans directed by Africans and African Americans 
(Jackson, 1997).iv  But this critique of the limited genome sample, while powerful, does little to upend the 
reliance on biologically based notions of racial taxonomies.  More to the point for our discussion here, 
this type of argument leaves the normativity of Whiteness unexamined by calling for further mapping of 
ostensibly genetically distinct racial groupings rather than interrogating the notion that Whiteness is a 
homogenous and genetically discreet category.  On the other hand, accepting the use of a limited, and 
predominantly Caucasian, DNA sample as “the map” of  “all humankind” morphs Whiteness into that 
which is universally human (Duster, 2001).   Returning again to Winant’s typology, neoconservative 
Whiteness combines a dual assertion of the universal alongside the assertion of the uniqueness of the 
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individual.  That Venter in his private venture used only his (Caucasian, male) DNA for mapping (Wade, 
2002a) passed with little comment because of the assumption of universality of this genetic sample: any 
(White) North American or northern European man is just as human as the next.    As it plays out in the 
Human Genome Project, the universal “shared inheritance of all humankind” is invoked by leaders of one 
faction of the HGP researchers, while another researcher asserts his individual curiosity about his own 
DNA.   In a very real sense, then, the mapping of the human genome is both a universal appeal to 
“humankind” and is based on the DNA of a putatively White genome.   Yet this is rarely explicitly stated 
or called into question.  Given the pervasiveness of Whiteness as a racialized norm in the U.S., it is not 
surprising that a map constructed from the DNA of northern Europeans and Americans is assumed to 
represent “the human” genome (Cross, 2001:435).   
Alongside and following shortly after the Human Genome Project began, genetic researchers, led 
by Luigi Luca Cavalli-Sforza of Stanford University, proposed the Human Genome Diversity Project 
(HGDP) in 1991.   Its explicit purpose was to map the diversity of the 0.1% of variation in human 
genomes by extracting genetic samples from a variety of geographically distinct populations, with a 
particular focus on indigenous peoples around the world.  These DNA samples were to be multiplied and 
stored for future research.  The Human Genome Diversity Project, unlike the Human Genome Project, has 
met with strenuous criticism (Dodson and Williamson, 1999; Greely, 2001; Katz Rothman, 2001; 
Reardon, 2001; Resnik, 1999).  Although the project languished without funding for a number of years, 
due in no small measure to opposition by indigenous people (Cross, 2001; Greely, 2001), it has recently 
been given new life in a formal working relationship with the HGP (Stevens, 2002:110).  The goal of 
mapping genetic “diversity” is doubly ironic, given both the minute proportion of variation (0.1%) and 
Sforza’s statement quoted above that “races do not exist” (Cavalli-Sforza, 1997).   As Jacqueline Stevens 
notes, Cavalli-Sforza’s statement that races do not exist is “overshadowed” by the HGDP, “for if they do 
not exist, then it makes no sense to study the small differences among them” (Stevens, 2002:109).   What 
is left unquestioned and unexamined here is the Whiteness of the baseline of comparison.   The variation 
of 0.1% is variation from some norm, and given the predominance of Caucasians in the sample 
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establishing that norm, it is a putatively White genomic standard; mapping the variation from that norm is 
a project inherently concerned with mapping difference from Whiteness.  
Undaunted by the criticisms and initial failure of the HGDP, another group of genetic researchers 
has proposed the “HapMap” project (Couzin, 2002; Gottleib, 2002).  One of the discoveries of the Human 
Genome Project was that many genes, rather than being transmitted to new generations at random, are 
passed down in blocks known as haplotypes (Gabriel and others, 2002).  These haplotypes remain largely 
unchanged through generations; therefore, genome researchers hypothesize that there may be only a 
handful of variations across the entire human population.  Further, some genetic researchers speculate that 
these small variations may play an important role in the development of diseases such as asthma, cancer, 
and diabetes (Collins, 1999).  Several countries involved in the HGP have already signed on to the 
HapMap project, and $100 million in funding will be shared by researchers in the U.S., Canada, Britain, 
China, and Japan (Couzin, 2002; Gottleib, 2002).  The research aim is to decode the genetic sources of 
disease by comparing the genomes of people in four ethnic groups: Japanese, Han Chinese, the Yoruba 
people of Nigeria, and Americans of northern and western European descent (Couzin, 2002).v  Clearly, 
the HapMap (like the HGDP) project holds the potential for naturalizing racial categories and challenging 
claims about the social construction of race by asserting a biological essence of race (Dunklee, 2003; 
Duster, 2003a; Katz Rothman, 2001; Stevens, 2002; 2003).  
The HapMap’s quest to find genetic markers for fundamentally social racial and ethnic groups, 
like the goal of the Human Genome Diversity Project, is a move away from the ostensibly universal 
notions of the Human Genome Project.   Indeed, Charles Murray (coauthor of The Bell Curve) has been 
quoted as saying: “As the HapMap project gets underway, this would seem to be a good time to put bets 
on the table regarding how the results will affect the ongoing debate about whether race is a valid and/or 
useful construct… the HapMap results will move the current consensus toward the traditional end.  Race 
will regain credibility as a useful, albeit imprecise, way to categorize human beings.”  (Quoted in Cohen 
and others, 2003) 
Here, the promise of genomic research in any sense of the universal (“we are all one,”  “99.9% 
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the same DNA”) has disappeared.   In its place is a move toward reconstructing “race”—and thus, 
inevitably Whiteness—in a manner that reproduces racial difference as immutable genetic difference.  
Many genomic researchers share an assumption that the goal of genetic research is to identify 
those specific genes and gene variants that influence the diagnosis, prevention, and treatment of disease, 
with little or no emphasis on race at a genomic level (Collins and others, 2003).  However, a subset of 
researchers continues to use self-identified and inherently social racial categorizations as a means to 
identify populations for genetic study, arguing that it is more economical to categorize people based on 
phenotypically based notions of “race” rather than to look exclusively at individual genetic composition 
for prevention, diagnosis, and treatment of disease (Risch and others, 2002).  Risch and colleagues argue 
that “population genetic studies have recapitulated the classical definition of races based on continental 
ancestry—namely African, Caucasian (Europe and Middle East), Asian, Pacific Islander (for example, 
Australian, New Guinean, and Melanesian), and Native American” (Risch and others, 2002:3).  The 
continued use of “race” as a heuristic device for investigation at the genomic level is paradoxical, when 
on its face individualized genetic therapy would mean testing and categorization on the individual level.  
This return to the use of classical racial categories in population genetics studies despite empirical 
evidence documenting the clear limits of these categories as indicative of ancestry or heritage (such as the 
U.S. census and birth record examples described earlier in this chapter) highlights the power of these 
socially constructed categories within science, as well as the role of scientific research in continuing to 




                       
Figure 1: The evolutionary tree of human races. Population genetic studies of world populations 
support the categorization into five major groups, as shown.  From Risch and others, 2002, fig. 1 
 
This is a particularly pernicious use of racial categories.  While the evidence from genetic research 
confirms the similarities of human beings across racial categories, geneticists like Risch want to continue 
to use social categories as a “practical” matter to underwrite the enormous costs of authentically 
individualized genetic testing and screening.    
As Bonham and colleagues point out, attributing racial variations in patterns of disease to the 
genetic composition of racial or ethnic groups is based on a series of imperfect assumptions.  Specifically, 
"self-identified race is a surrogate for ancestral geographic origin, which is a surrogate for variation 
across the genome, which is a surrogate for variation in disease-relevant alleles, which is a surrogate for 
individual disease risk" (Bonham, Warshauer-Baker, and Collins, 2005:13, citing Collins, 2004).  With 
each imperfect assumption, the link between socially constructed racial categories and genetic sources of 
disease gets less clear, like a copy of a copy of a copy that continues to blur with each reproduction; yet 
the genetic frame, and the supposedly biological basis for Whiteness, remains unchallenged.   This 
reliance on race as a sorting mechanism of convenience in the face of genomic research that demonstrates 
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this is a less than completely reliable proxy simultaneously naturalizes racial disparities while it holds out 
the promise of eliminating racial disparities in health. And it leaves the Whiteness within those disparities 
unexamined.   
Furthermore, scholars have also pointed out the impulse to attach genetic conditions to labeled 
racial or ethnic groups, while those attached to “Whites” remain invisible.  For example, genetically 
linked conditions such as Tay-Sachs or sickle cell anemia have become labeled as “Jewish” and “Black” 
diseases respectively because they are associated with people who are descendants of Ashkenazi Jews and 
African Americans.  However, a disease such as cystic fibrosis, which is genetically linked to subgroups 
of the White population, does not get labeled as difference (Katz Rothman, 1998).    The link, then, 
between genetic condition and Whiteness is ephemeral, while the connection between genetic condition 
and members of (already) labeled racial and ethnic groups is intractable.  Schwalbe and colleagues have 
pointed to the process of identifying and labeling groups as crucial to the process of reproducing 
inequalities (Schwalbe and others, 2000).  Thus, the HapMap’s explicit quest to locate difference at the 
genetic level contributes to a Whiteness project that both reifies racial categories and contributes to the 
identification of disease risk as located within racialized groups.    
Returning again to Winant’s typology of different Whiteness projects, the “classical” definition of 
races mentioned here seems to move away from the neoconservative Whiteness project and toward the far 
right Whiteness project of biological essentialism.   Indeed, Risch’s “evolutionary tree of human races” is 
actually quite close to de Gobineau’s conceptualization in Inequality of the Races (1853), an essay widely 
regarded as crucial in the development of contemporary Western “racist culture” (Goldberg, 1993).  Here 
we have moved fully from the neoconservative racial project on to the far right racial project in which 
race is seen as biologically based and Whiteness morphs (Duster, 2001) into a discrete line, distinct from 
others and solidified.  Thus, the explicit quest to locate difference at the genetic level contributes to a 
Whiteness project that reifies racial categories and return to pre-Civil Rights Movement constructions of 




WHITENESS IN HEALTH DISPARITIES RESEARCH 
 
Scholars both within and outside the field of public health have drawn attention to the limits of 
analyses and interventions that focus on biological or behavioral explanations for health and disease, 
without understanding the social contexts within which health and disease are produced (Geronimus, 
2000; House and others, 1994; House and Williams, 2000; Link and Phelan, 1995; Lupton, 1995; Schulz 
and others, 2002; Williams and Collins, 2001).  Specifically, they have argued that such a focus serves to 
locate the causes of poor health within the bodies of those individuals or groups who are most visibly 
affected by social, economic, and political powerlessness while drawing attention away from the broader 
social processes that influence opportunities for health as well as risk of disease (Lupton, 1995; Muntaner, 
1999; Shah, 2001).   
In this chapter, we have examined one aspect of this process —the ways that race and Whiteness 
are constructed in the literature on racial disparities in health and the ways that this literature may 
contribute to the reification or reproduction of the racial categories that are fundamental to the production 
of racial inequalities (Schwalbe and others, 2000).  We suggest that this challenge resurfaces particularly 
in the absence of a specifically social theory of race, and of whiteness.  Following Muntaner (1999), we 
argue that the absence of an explicitly social theory of race allows a wide range of interpretations of racial 
disparities in health to emerge, implicitly or explicitly locating the causes of health and disease within 
individuals, particular groups (e.g., Mexicans, Chinese Americans, the poor), or social relations (e.g., 
hierarchies of race and class).   
These interpretations, each of which can be linked to various Whiteness or, more broadly, racial, 
projects, do not occur in isolation from the larger social and political context.  Over the past several 
decades in the United States, neoliberal and neoconservative Whiteness projects have been in constant 
flux.  Recently, as the mainstream of U.S. politics has moved rightward, challenges have emerged to 
social and behavioral epidemiological research on health disparities (Zielhuis and Kiemeny, 2001), while 
biomedical and genomic research on racial disparities in health have reemerged.     
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Nelkin and Lindee suggested a decade ago that the power of genetic explanations for racial 
disparities in health may derive in part from the exoneration of the individual, “removing moral 
responsibility by providing a biological ‘excuse.’ Genes are the agents of destiny: We are the victims of a 
molecule, captives of our heredity” (1995:129).  Yet, as Kaufman and Hall point out more recently, “The 
myth of genetic determinism cuts both ways, however, for although it absolves the individual from 
responsibility, it also absolves the society at large.  Deterministic biological explanations (‘it’s in my 
genes’)—much like theological explanations (‘the devil made me do it’)—locate problems (and therefore 
solutions) within individuals” (2003:117).  Genetic explanations for racial disparities in health ignore the 
historically situated and contextual nature of processes of racialization, shifting the lens away from the 
ways that those processes are linked to the social, political, and economic conditions that influence health.  
Instead, by locating the cause of health disparities within the genes—or haplotypes—of racialized groups, 
they suggest that there is “something innately pathologic” about that group, reinforcing their “essential 
physical inferiority in the modern world.” (2003:117). Such interpretations obscure the social processes 
that create inequality, contribute to the stigmatization of racialized groups (and thus perpetuate 
inequalities), and allow Whiteness to remain invisible and uninterrogated. 
While we have focused particular attention on genetic research in the latter half of this chapter, 
this same process may play out with any research that does not put forward a specifically social theory of 
race.  For example, research into the extent to which behaviors or cultural practices contribute to racial 
disparities in health, without explicit theoretical linkages to social and historical contexts, can reproduce 
ideas of immutable difference between racial groups.  To the extent that culture, for example, comes to be 
perceived as an innate characteristic distinct to particular racial or ethnic groups, it “inherits the role of 
race…[and] becomes determinist and teleological,” reproducing the idea of inherent differences between 
groups (Malik, 1996:150).   
Explicitly theorizing race as a social construct encourages us to examine how processes of 
racialization are linked to social, political, and economic conditions that, in turn, influence health 
outcomes.  By moving beyond the use of race as an atheoretical and ahistorical category and toward 
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analysis of the processes through which racial constructs are produced and linked to differences in health, 
researchers can contribute to etiologic research that identifies the underlying—or fundamental—causes of 
racial disparities in health.  This includes an understanding of the ways that race is implicated in the 
construction of class, as well as the ways that class is implicated in the construction of race (Buck, 2001).   
Even more so, it is imperative for those vested in understanding and addressing health 
disparities—whether population geneticists, social epidemiologists, or public health practitioners—to 
examine critically the assumptions and implicit as well as explicit theoretical frameworks that we bring to 
our work.  Only in so doing can we begin to understand the ways that socially constructed racial 
categories permeate our own implicit assumptions and interpretations, as well as the ways that research on 
racial disparities in health may, advertently or inadvertently, reproduce the racial categories that are 
themselves fundamental to the processes of inequality.  Scholars who make explicit connections between 
social conditions and the historical and locally contingent production of Whiteness and its connections to 
relative advantage in the distribution of material, political, and cultural resources begin to disrupt the 
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NOTES 
                                                 
i PubMed search conducted February 2005 using search terms “racial disparities.”    
ii The International Human Genome Sequencing Consortium includes:  
1. The Whitehead Institute/MIT Center for Genome Research, Cambridge, Mass., U.S.  
2. The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, 
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Cambridgeshire, U.K.  
3. Washington University School of Medicine Genome Sequencing Center, St. Louis, Mo., U.S.  
4. United States DOE Joint Genome Institute, Walnut Creek, Calif., U.S.  
5. Baylor College of Medicine Human Genome Sequencing Center, Department of Molecular and Human 
Genetics, Houston, Tex., U.S.  
6. RIKEN Genomic Sciences Center, Yokohama, Japan  
7. Genoscope and CNRS UMR-8030, Evry, France  
8. GTC Sequencing Center, Genome Therapeutics Corporation, Waltham, Mass., U.S.  
9. Department of Genome Analysis, Institute of Molecular Biotechnology, Jena, Germany  
10. Beijing Genomics Institute/Human Genome Center, Institute of Genetics, Chinese Academy of 
Sciences, Beijing, China  
11. Multimegabase Sequencing Center, The Institute for Systems Biology, Seattle, Wash.  
12. Stanford Genome Technology Center, Stanford, Calif., U.S.  
13. Stanford Human Genome Center and Department of Genetics, Stanford University School of 
Medicine, Stanford, Calif., U.S.  
14. University of Washington Genome Center, Seattle, Wash., U.S.  
15. Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan  
16. University of Texas Southwestern Medical Center at Dallas, Dallas, Tex., U.S.  
17. University of Oklahoma's Advanced Center for Genome Technology, Dept. of Chemistry and 
Biochemistry, University of Oklahoma, Norman, Okla., U.S.  
18. Max Planck Institute for Molecular Genetics, Berlin, Germany  
19. Cold Spring Harbor Laboratory, Lita Annenberg Hazen Genome Center, Cold Spring Harbor, N.Y., 
U.S.  
20. GBF - German Research Centre for Biotechnology, Braunschweig, Germany 
 
iii Since he had his DNA sequenced, Venter has been following an individually tailored regime for a 
condition that is known to be a precursor to Alzheimer’s (Wade, 2002a).   Most of the genetic research 
community involved in mapping the human genome found Venter’s announcement less than noteworthy.   
Collins of the NHGRI, who shared the joint press conference with Venter, declined to comment on the 
revelation (Wade, 2002a).       
 
iv And, indeed, a project known as G-RAP, Genomic Research in African-American Pedigree, is under 
way at Howard University, based precisely on the notion of understanding "gene-based differences."     
v According to a News Advisory titled “Background on Ethical and Sampling Issues Raised by the 
International HapMap Project,” the NHGRI’s website describes the rationale for selecting these groups in 
these terms: “These four populations were selected to include people with ancestry from widely separate 
geographic regions. Researchers have found that most human populations share the common haplotype 
patterns. Research already suggests that the overall organization of genetic variation is similar in all four 
populations, but that there will be enough differences in haplotype frequencies to justify genome-wide 
studies of samples from these populations.”  [http://genome.gov/10005337 ].  Accessed March 28, 2005. 
